CREDIT SUISSE AG/ - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 247 filers reported holding SAGE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.22 and the average weighting 0.2%.

Quarter-by-quarter ownership
CREDIT SUISSE AG/ ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,344,536
-46.3%
113,923
+22.8%
0.00%
-50.0%
Q2 2023$4,362,845
+8.0%
92,787
-3.6%
0.00%0.0%
Q1 2023$4,038,020
+4.6%
96,235
-5.0%
0.00%0.0%
Q4 2022$3,861,636
+1.5%
101,249
+4.2%
0.00%0.0%
Q3 2022$3,806,000
+21.4%
97,207
+0.2%
0.00%
+33.3%
Q2 2022$3,134,000
+1.5%
97,016
+4.0%
0.00%0.0%
Q1 2022$3,087,000
-10.3%
93,308
+15.3%
0.00%
+50.0%
Q4 2021$3,443,000
+6.5%
80,947
+11.0%
0.00%0.0%
Q3 2021$3,232,000
-20.4%
72,942
+2.0%
0.00%0.0%
Q2 2021$4,061,000
+3.1%
71,486
+35.8%
0.00%0.0%
Q1 2021$3,939,000
-29.9%
52,631
-19.0%
0.00%
-33.3%
Q4 2020$5,618,000
+30.9%
64,946
-7.5%
0.00%0.0%
Q3 2020$4,293,000
-10.3%
70,249
-39.0%
0.00%0.0%
Q2 2020$4,786,000
+91.1%
115,108
+31.9%
0.00%
+50.0%
Q1 2020$2,505,000
-44.7%
87,251
+39.1%
0.00%
-33.3%
Q4 2019$4,528,000
-1.3%
62,734
+91.9%
0.00%
-25.0%
Q3 2019$4,587,000
-42.7%
32,692
-25.3%
0.00%
-42.9%
Q2 2019$8,009,000
-54.6%
43,745
-60.5%
0.01%
-56.2%
Q1 2019$17,635,000
+535.7%
110,873
+282.9%
0.02%
+433.3%
Q4 2018$2,774,000
-40.0%
28,958
-11.5%
0.00%
-25.0%
Q3 2018$4,620,000
-14.8%
32,709
-5.5%
0.00%
-20.0%
Q2 2018$5,420,000
-35.8%
34,628
-33.9%
0.01%
-37.5%
Q1 2018$8,440,000
+22.3%
52,400
+25.0%
0.01%
+33.3%
Q4 2017$6,902,000
+42.1%
41,907
-46.3%
0.01%
+20.0%
Q3 2017$4,857,000
-3.7%
77,977
+23.1%
0.01%0.0%
Q2 2017$5,044,000
-18.9%
63,347
-27.6%
0.01%
-16.7%
Q1 2017$6,217,000
+0.9%
87,489
-27.5%
0.01%0.0%
Q4 2016$6,162,000
+105.7%
120,685
+85.5%
0.01%
+100.0%
Q3 2016$2,996,000
+186.2%
65,052
+87.0%
0.00%
+200.0%
Q2 2016$1,047,000
-10.3%
34,783
-4.4%
0.00%0.0%
Q1 2016$1,167,000
+200.8%
36,401
+446.2%
0.00%
Q4 2015$388,000
-41.7%
6,665
-57.7%
0.00%
-100.0%
Q3 2015$666,000
-78.6%
15,762
-63.0%
0.00%
-66.7%
Q2 2015$3,109,000
+197.8%
42,594
+104.9%
0.00%
+200.0%
Q1 2015$1,044,000
+172.6%
20,784
+98.2%
0.00%
Q4 2014$383,00010,4850.00%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 5,149,482$105,976,3402.24%
Palo Alto Investors LP 1,005,776$20,698,8701.96%
Boxer Capital, LLC 1,094,000$22,514,5201.20%
Bellevue Group AG 3,513,351$72,304,7641.16%
PDT Partners, LLC 181,625$3,737,8430.47%
EASTERLY INVESTMENT PARTNERS LLC 195,643$4,026,3330.44%
Harvest Investment Services, LLC 30,302$623,6150.40%
Simplify Asset Management Inc. 120,030$2,470,2170.28%
SAMLYN CAPITAL, LLC 739,867$15,226,4630.25%
CAXTON ASSOCIATES LP 68,035$1,400,1600.19%
View complete list of SAGE THERAPEUTICS INC shareholders